Roshawn Blunt

Roshawn Blunt serves as a Venture Partner at Omega Funds and holds board memberships at Reneo Pharmaceuticals and Kronos Bio. Additionally, Roshawn is the Managing Director at both 1798 and The Aequitas Group. Roshawn's educational background includes an MBA in Marketing and Biotechnology from Northwestern University's Kellogg School of Management and an AB in International and Public Affairs from Princeton University.